| Entry |
|
|---|
| Name |
Mitindomide (USAN/INN) |
|---|
| Formula |
C14H12N2O4
|
|---|
| Exact mass |
272.0797
|
|---|
| Mol weight |
272.26
|
|---|
| Structure |
|
|---|
| Class |
Antineoplastic
DG03350 Thalidomide derivative
|
|---|
| Efficacy |
Antineoplastic |
|---|
| Target |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antineoplastic
DG03350 Thalidomide derivative
D05054 Mitindomide
Target-based classification of drugs [BR:br08310]
Enzymes
Isomerases (EC5)
DNA topoisomerase
TOP2
D05054 Mitindomide (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 20
1 C1y C 26.7400 -26.6700
2 C2x C 26.7400 -25.2700
3 C1y C 27.9300 -27.3700
4 C2x C 27.4400 -26.4600
5 C1y C 26.2500 -28.6300
6 C1y C 28.6300 -28.6300
7 C1y C 27.4400 -27.9300
8 C1y C 25.4800 -27.4400
9 C5x C 24.1500 -27.7900
10 N1x N 24.0800 -29.1900
11 C5x C 25.3400 -29.6800
12 C1y C 29.8900 -27.9300
13 C1y C 29.1900 -26.6700
14 C5x C 31.2900 -27.6500
15 N1x N 31.5000 -26.2500
16 C5x C 30.1700 -25.6200
17 O5x O 29.8900 -24.2200
18 O5x O 32.3400 -28.6300
19 O5x O 25.6900 -31.0100
20 O5x O 23.0300 -26.8800
BOND 24
1 1 2 1
2 1 3 1
3 2 4 2
4 3 6 1
5 4 7 1
6 5 7 1
7 6 7 1
8 8 9 1
9 9 10 1
10 10 11 1
11 11 5 1
12 8 5 1
13 1 8 1
14 6 12 1
15 12 13 1
16 3 13 1
17 12 14 1
18 14 15 1
19 15 16 1
20 13 16 1
21 16 17 2
22 14 18 2
23 11 19 2
24 9 20 2
|
|---|
